Search Results | Cancer Research | American Association for Cancer Research

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Abstract B37: PSCA haploinsufficiency enhances prostate tumor growth in prostate-specific Pten knockout mice

Miranda L. Moore, Shuai Tang, Mark C. Willingham, Purnima Dubey

Cancer Res (2009) 69 (23_Supplement): B37.

DOI: https://doi.org/10.1158/0008-5472.FBCR09-B37

Published: 28 October 2014

View article

Journal Articles

Critical Roles of DMP1 in Human Epidermal Growth Factor Receptor 2/neu-Arf-p53 Signaling and Breast Cancer Development

Pankaj Taneja, Dejan Maglic, Fumitake Kai, Takayuki Sugiyama, Robert D. Kendig, Donna P. Frazier, Mark C. Willingham, Kazushi Inoue

Cancer Res (2010) 70 (22): 9084–9094.

DOI: https://doi.org/10.1158/0008-5472.CAN-10-0159

Published: 14 November 2010

View article

Includes: Supplementary data

Journal Articles

In situ Vaccination Combined with Androgen Ablation and Regulatory T-Cell Depletion Reduces Castration-Resistant Tumor Burden in Prostate-Specific Pten Knockout Mice

Elizabeth J. Akins, Miranda L. Moore, Shuai Tang, Mark C. Willingham, Janet A. Tooze, Purnima Dubey

Cancer Res (2010) 70 (9): 3473–3482.

DOI: https://doi.org/10.1158/0008-5472.CAN-09-2490

Published: 28 April 2010

View article

Includes: Supplementary data

Journal Articles

Abstract 1096: Arf-independent activation of p53 by the Dmp1 tumor suppressor

Fumitake Kai, Robert D. Kendig, Donna P. Frazier, Pankaj Taneja, Dejan Maglic, Takayuki Sugiyama, Elizabeth A. Fry, Mark C. Willingham, Kazushi Inoue

Cancer Res (2010) 70 (8_Supplement): 1096.

DOI: https://doi.org/10.1158/1538-7445.AM10-1096

Published: 15 April 2010

View article

Journal Articles

Topology of NGEP, a Prostate-Specific Cell:Cell Junction Protein Widely Expressed in Many Cancers of Different Grade Level

Sudipto Das, Yoonsoo Hahn, Dawn A. Walker, Satoshi Nagata, Mark C. Willingham, Donna M. Peehl, Tapan K. Bera, Byungkook Lee, Ira Pastan

Cancer Res (2008) 68 (15): 6306–6312.

DOI: https://doi.org/10.1158/0008-5472.CAN-08-0870

Published: 01 August 2008

View article

Includes: Supplementary data

Journal Articles

NGEP, a Prostate-Specific Plasma Membrane Protein that Promotes the Association of LNCaP Cells

Sudipto Das, Yoonsoo Hahn, Satoshi Nagata, Mark C. Willingham, Tapan K. Bera, Byungkook Lee, Ira Pastan

Cancer Res (2007) 67 (4): 1594–1601.

DOI: https://doi.org/10.1158/0008-5472.CAN-06-2673

Published: 16 February 2007

View article

Journal Articles

Phase I and phase II enzyme polymorphisms and p53 mutations in breast cancer.

Beth O. Van Emburgh, Jennifer J. Hu, Edward A. Levine, Libyadda J. Mosley, Douglass L. Case, Sommer N. Knight, Nancy D. Perrier, Peter Rubin, Gary B. Sherrill, Cindy S. Shaw, Lisa A. Carey, Lynda R. Sawyer, Mark C. Willingham, Mark S. Miller

Cancer Res (2006) 66 (8_Supplement): 1267.

Published: 15 April 2006

View article

Journal Articles

Polymorphisms in Phase I and Phase II enzymes and mutations in p53

Beth O. Van Emburgh, Jennifer J. Hu, Edward A. Levine, Libyadda J. Mosley, Sommer N. Knight, Nancy D. Perrier, Jessica Watkins, Elisabeth Curtis, Peter Rubin, Gary B. Sherrill, Cindy S. Shaw, Mark C. Willingham, Edward S. Peters, Mark S. Miller

Cancer Res (2005) 65 (9_Supplement): 1162–1163.

Published: 01 May 2005

View article

Journal Articles

Synergistic cytotoxicity of combinations of DAB₃₈₉EGF and IL13PE38QQR fusion proteins on human glioma cell lines.

Tie F. Liu, Mark C. Willingham, Stephen B. Tatter, Kimberley A. Cohen, Corinne A. Lowe, Andrew Thorburn, Arthur E. Frankel

Cancer Res (2004) 64 (7_Supplement): 507–508.

Published: 01 April 2004

View article

Journal Articles

Mutant Thyroid Hormone Receptor β Represses the Expression and Transcriptional Activity of Peroxisome Proliferator-activated Receptor γ during Thyroid Carcinogenesis

Hao Ying, Hideyo Suzuki, Li Zhao, Mark C. Willingham, Paul Meltzer, Sheue-Yann Cheng

Cancer Res (2003) 63 (17): 5274–5280.

Published: 18 September 2003

View article

Journal Articles

A Diphtheria Toxin-Epidermal Growth Factor Fusion Protein Is Cytotoxic to Human Glioblastoma Multiforme Cells

Tie Fu Liu, Kimberley A. Cohen, Jason G. Ramage, Mark C. Willingham, Andrew M. Thorburn, Arthur E. Frankel

Cancer Res (2003) 63 (8): 1834–1837.

Published: 15 April 2003

View article

Journal Articles

Influence of Coenzyme A-independent Transacylase and Cyclooxygenase Inhibitors on the Proliferation of Breast Cancer Cells

Anthony J. Trimboli, B. Moseley Waite, Gen-ichi Atsumi, Alfred N. Fonteh, Andrew M. Namen, Carl E. Clay, Tim E. Kute, Kevin P. High, Mark C. Willingham, Floyd H. Chilton

Cancer Res (1999) 59 (24): 6171–6177.

Published: 01 December 1999

View article

Journal Articles

Interleukin 2 (IL-2) Receptor Expression and Sensitivity to Diphtheria Fusion Toxin DAB₃₈₉IL-2 in Cultured Hematopoietic Cells

Gian G. Re, Cory Waters, Louis Poisson, Mark C. Willingham, Kazuo Sugamura, Arthur E. Frankel

Cancer Res (1996) 56 (11): 2590–2595.

Published: 01 June 1996

View article

Journal Articles

Tumor-specific Anti-Epidermal Growth Factor Receptor Variant III Monoclonal Antibodies: Use of the Tyramine-Cellobiose Radioiodination Method Enhances Cellular Retention and Uptake in Tumor Xenografts

Craig J. Reist, Gary E. Archer, Shekar N. Kurpad, Carol J. Wikstrand, Ganesan Vaidyanathan, Mark C. Willingham, David K. Moscatello, Albert J. Wong, Darell D. Bigner, Michael R. Zalutsky

Cancer Res (1995) 55 (19): 4375–4382.

Published: 01 October 1995

View article

Journal Articles

Antitumor Effects of B3-PE and B3-LysPE40 in a Nude Mouse Model of Human Breast Cancer and the Evaluation of B3-PE Toxicity in Monkeys

Lee H. Pai, Janendra K. Batra, David J. FitzGerald, Mark C. Willingham, Ira Pastan

Cancer Res (1992) 52 (11): 3189–3193.

Published: 01 June 1992

View article

Journal Articles

Characterization of the Antigen (CAK1) Recognized by Monoclonal Antibody K1 Present on Ovarian Cancers and Normal Mesothelium

Kai Chang, Lee H. Pai, Janendra K. Batra, Ira Pastan, Mark C. Willingham

Cancer Res (1992) 52 (1): 181–186.

Published: 01 January 1992

View article

Journal Articles

Characterization of Monoclonal Antibodies B1 and B3 That React with Mucinous Adenocarcinomas

Ira Pastan, Elizabeth T. Lovelace, Maria G. Gallo, Angelina V. Rutherford, John L. Magnani, Mark C. Willingham

Cancer Res (1991) 51 (14): 3781–3787.

Published: 01 July 1991

View article

Journal Articles

Enhancement of the Activity of Immunotoxins by Analogues of Verapamil

Robert Pirker, David J. P. FitzGerald, Manfred Raschack, Zimmermann Frank, Mark C. Willingham, Ira Pastan

Cancer Res (1989) 49 (17): 4791–4795.

Published: 01 September 1989

View article

Journal Articles

Chemoimmunotoxin Therapy against a Human Colon Tumor (HT-29) Xenografted into Nude Mice

John W. Pearson, David J. P. FitzGerald, Mark C. Willingham, Robert H. Wiltrout, Ira Pastan, Dan L. Longo

Cancer Res (1989) 49 (13): 3562–3567.

Published: 01 July 1989

View article

Journal Articles

Enhancement of the Activity of Immunotoxins Made with Either Ricin A Chain or Pseudomonas Exotoxin in Human Ovarian and Epidermoid Carcinoma Cell Lines

Robert Pirker, David J. P. FitzGerald, Mark C. Willingham, Ira Pastan

Cancer Res (1988) 48 (14): 3919–3923.

Published: 01 July 1988

View article

NARROW

Abstract B37: PSCA haploinsufficiency enhances prostate tumor growth in prostate-specific Pten knockout mice

Critical Roles of DMP1 in Human Epidermal Growth Factor Receptor 2/neu-Arf-p53 Signaling and Breast Cancer Development

In situ Vaccination Combined with Androgen Ablation and Regulatory T-Cell Depletion Reduces Castration-Resistant Tumor Burden in Prostate-Specific Pten Knockout Mice

Abstract 1096: Arf-independent activation of p53 by the Dmp1 tumor suppressor

Topology of NGEP, a Prostate-Specific Cell:Cell Junction Protein Widely Expressed in Many Cancers of Different Grade Level

NGEP, a Prostate-Specific Plasma Membrane Protein that Promotes the Association of LNCaP Cells

Phase I and phase II enzyme polymorphisms and p53 mutations in breast cancer.

Polymorphisms in Phase I and Phase II enzymes and mutations in p53

Synergistic cytotoxicity of combinations of DAB₃₈₉EGF and IL13PE38QQR fusion proteins on human glioma cell lines.

Mutant Thyroid Hormone Receptor β Represses the Expression and Transcriptional Activity of Peroxisome Proliferator-activated Receptor γ during Thyroid Carcinogenesis

A Diphtheria Toxin-Epidermal Growth Factor Fusion Protein Is Cytotoxic to Human Glioblastoma Multiforme Cells

Influence of Coenzyme A-independent Transacylase and Cyclooxygenase Inhibitors on the Proliferation of Breast Cancer Cells

Interleukin 2 (IL-2) Receptor Expression and Sensitivity to Diphtheria Fusion Toxin DAB₃₈₉IL-2 in Cultured Hematopoietic Cells

Tumor-specific Anti-Epidermal Growth Factor Receptor Variant III Monoclonal Antibodies: Use of the Tyramine-Cellobiose Radioiodination Method Enhances Cellular Retention and Uptake in Tumor Xenografts

Antitumor Effects of B3-PE and B3-LysPE40 in a Nude Mouse Model of Human Breast Cancer and the Evaluation of B3-PE Toxicity in Monkeys

Characterization of the Antigen (CAK1) Recognized by Monoclonal Antibody K1 Present on Ovarian Cancers and Normal Mesothelium

Characterization of Monoclonal Antibodies B1 and B3 That React with Mucinous Adenocarcinomas

Enhancement of the Activity of Immunotoxins by Analogues of Verapamil

Chemoimmunotoxin Therapy against a Human Colon Tumor (HT-29) Xenografted into Nude Mice

Enhancement of the Activity of Immunotoxins Made with Either Ricin A Chain or Pseudomonas Exotoxin in Human Ovarian and Epidermoid Carcinoma Cell Lines

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only